Kamu erişimi zorunlu olan makaleler - Albrecht Stenzinger, MDDaha fazla bilgi edinin
GenelBMBFDFGHelmholtzNIHEuropean CommissionCancer Research UKNIHRANRSCLHFSPDoDVANHMRCHEAMRCGovernment of ItalySFIBreast Cancer Now, UKEPSRCGovernment of SpainKWFSusan G. KomenHHMIVolkswagen FoundationWellcomeNKFIAIRC Foundation for Cancer Research in ItalyBrain Tumour Charity, UKVinnova, SwedenCIHRNWOYorkshire Cancer Research, UKFNRState of CalifoniaUK Research & InnovationV Foundation, USAOICR
Hiçbir yerde sunulmuyor: 39
NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
C Heining, P Horak, S Uhrig, PL Codo, B Klink, B Hutter, M Fröhlich, ...
Cancer discovery 8 (9), 1087-1095, 2018
Zorunlu olanlar: Helmholtz Association, Federal Ministry of Education and Research, Germany
Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers
P Horak, C Heining, S Kreutzfeldt, B Hutter, A Mock, J Hüllein, M Fröhlich, ...
Cancer discovery 11 (11), 2780-2795, 2021
Zorunlu olanlar: Helmholtz Association
Size matters: dissecting key parameters for panel‐based tumor mutational burden analysis
I Buchhalter, E Rempel, V Endris, M Allgäuer, O Neumann, AL Volckmar, ...
International journal of cancer 144 (4), 848-858, 2019
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels
V Endris, I Buchhalter, M Allgäuer, E Rempel, A Lier, AL Volckmar, ...
International journal of cancer 144 (9), 2303-2312, 2019
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Variant classification in precision oncology
J Leichsenring, P Horak, S Kreutzfeldt, C Heining, P Christopoulos, ...
International Journal of Cancer 145 (11), 2996-3010, 2019
Zorunlu olanlar: Helmholtz Association
Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma
P Christopoulos, M Kirchner, F Bozorgmehr, V Endris, M Elsayed, ...
International Journal of Cancer 144 (1), 190-199, 2019
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Cancer beyond organ and tissue specificity: next‐generation‐sequencing gene mutation data reveal complex genetic similarities across major cancers
D Heim, J Budczies, A Stenzinger, D Treue, P Hufnagl, C Denkert, ...
International journal of cancer 135 (10), 2362-2369, 2014
Zorunlu olanlar: Human Frontier Science Program
Mutational diversity and therapy response in breast cancer: a sequencing analysis in the neoadjuvant GeparSepto trial
S Loibl, D Treue, J Budczies, K Weber, A Stenzinger, WD Schmitt, ...
Clinical Cancer Research 25 (13), 3986-3995, 2019
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan‐cancer survey with implications for the use of immune checkpoint inhibitors
J Budczies, M Bockmayr, F Klauschen, V Endris, S Fröhling, ...
Genes, Chromosomes and Cancer 56 (8), 651-659, 2017
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Copy number changes of clinically actionable genes in melanoma, non‐small cell lung cancer and colorectal cancer—A survey across 822 routine diagnostic cases
N Pfarr, R Penzel, F Klauschen, D Heim, R Brandt, D Kazdal, ...
Genes, Chromosomes and Cancer 55 (11), 821-833, 2016
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Fully automatic deep learning in bi-institutional prostate magnetic resonance imaging: effects of cohort size and heterogeneity
N Netzer, C Weißer, P Schelb, X Wang, X Qin, M Görtz, V Schütz, ...
Investigative radiology 56 (12), 799-808, 2021
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing
P Christopoulos, M Kirchner, J Roeper, F Saalfeld, M Janning, ...
Lung cancer 148, 105-112, 2020
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
A Stenzinger, A Edsjö, C Ploeger, M Friedman, S Fröhling, V Wirta, ...
Seminars in cancer biology 84, 242-254, 2022
Zorunlu olanlar: Vinnova, Sweden
RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours
T Longerich, V Endris, O Neumann, E Rempel, M Kirchner, Z Abadi, ...
Gut 68 (7), 1287-1296, 2019
Zorunlu olanlar: German Research Foundation, Federal Ministry of Education and Research, Germany
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement
J Budczies, D Kazdal, M Allgäuer, P Christopoulos, E Rempel, N Pfarr, ...
Lung Cancer 142, 114-119, 2020
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
KIT-dependent and KIT-independent genomic heterogeneity of resistance in gastrointestinal stromal tumors—TORC1/2 inhibition as salvage strategy
T Mühlenberg, J Ketzer, MC Heinrich, S Grunewald, A Marino-Enriquez, ...
Molecular cancer therapeutics 18 (11), 1985-1996, 2019
Zorunlu olanlar: US Department of Veterans Affairs
Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance
N Pfarr, R Penzel, V Endris, C Lier, C Flechtenmacher, AL Volckmar, ...
Genes, Chromosomes and Cancer 56 (4), 255-265, 2017
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Validating comprehensive next-generation sequencing results for precision oncology: the NCT/DKTK molecularly aided stratification for tumor eradication research experience
A Lier, R Penzel, C Heining, P Horak, M Fröhlich, S Uhrig, J Budczies, ...
JCO Precision Oncology 2, 1-13, 2018
Zorunlu olanlar: Helmholtz Association
Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas
S Dietz, A Lifshitz, D Kazdal, A Harms, V Endris, H Winter, A Stenzinger, ...
International journal of cancer 144 (5), 1061-1072, 2019
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Combined immunohistochemistry after mass spectrometry imaging for superior spatial information
K Kriegsmann, R Longuespée, M Hundemer, C Zgorzelski, R Casadonte, ...
PROTEOMICS–Clinical Applications 13 (1), 1800035, 2019
Zorunlu olanlar: Federal Ministry of Education and Research, Germany
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir